Kohshi Nishiguchi
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease.
Journal: International journal of clinical pharmacology and therapeutics
Published: January 16, 2026
Association between antibody-dependent cellular cytotoxicity activity of antitumor antibodies and infusion reactions: a pharmacovigilance analysis using the Japanese adverse drug event report database.
Journal: Journal of pharmaceutical health care and sciences
Published: April 14, 2025
Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy.
Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy.
Journal: Biological & pharmaceutical bulletin
Published: July 02, 2023
Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen.
Journal: Cancer chemotherapy and pharmacology
Published: June 17, 2022
Optimal Sampling Strategy and Threshold of Serum Vancomycin Concentration in Elderly Japanese Patients Undergoing High-Flux Hemodialysis.
Journal: Therapeutic drug monitoring
Published: May 11, 2021
Factors Associated with Dose Modification of Lenalidomide Plus Dexamethasone Therapy in Multiple Myeloma.
Journal: Biological & pharmaceutical bulletin
Published: August 04, 2020
In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: May 22, 2020
Olaparib Potentiates Anticancer Drug Cytotoxicity via 53BP1 in Oesophageal Squamous Cell Carcinoma Cells.
Journal: Anticancer research
Published: December 19, 2019
Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells.
Journal: Scientific reports
Published: May 23, 2019
A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia.
Journal: Journal of clinical pharmacy and therapeutics
Published: March 11, 2019
Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines.
Journal: Anticancer research
Published: January 22, 2019
Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia .
Journal: International journal of clinical pharmacology and therapeutics
Published: May 25, 2018
Last Updated: 09/26/2026